| Tiotropium | Salmeterol | Difference | |
| 1 yr | |||
| QALYs | 0.746 (0.726–0.762) | 0.734 (0.700–0.755) | 0.012 (-0.017–0.048) |
| Total costs SHI perspective | 1186 (1110–1269) | 1069 (951–1202) | 116 (-32–262) |
| Total costs societal perspective | 1570 (1474–1668) | 1380 (1239–1532) | 190 (10–363) |
| 5 yrs | |||
| QALYs | 3.26 (3.04–3.43) | 3.18 (2.78–3.42) | 0.082 (-0.250–0.519) |
| Total costs SHI perspective | 5659 (5135–6168) | 5372 (4516–6222) | 287 (-707–1282) |
| Total costs societal perspective | 7520 (6850–8138) | 6896 (5806–7937) | 625 (-595–1869) |
Data are presented as mean (95% uncertainty interval). QALYs: quality-adjusted life years; SHI: statutory healthcare insurance.